Quinine Sulfate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 300 mg, 324 mg, 325 mg, 648 mg
Reference Brands: Qualaquin(US)
Category:
Medical Aid
Quinine sulfate inhibits the parasite's heme polymerase, preventing detoxification of toxic heme produced during hemoglobin digestion. This leads to parasite death. Benefits include effective treatment of uncomplicated malaria, rapid symptom relief, and high efficacy against resistant strains, making it a vital option when other antimalarials fail or are unavailable.
Quinine Sulfate Tablets is available in Tablet
and strengths such as 300 mg, 324 mg, 325 mg, 648 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Quinine Sulfate Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Quinine Sulfate Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Quinine sulfate tablets are approved in the EU and US for the treatment of uncomplicated malaria. In the US, brands like Qualaquin are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and quality standards, though use is limited due to side effects. In the EU, approval depends on national regulations, with dossiers including clinical trial data and manufacturing practices. Both regions require detailed dossiers for approval, including pharmacovigilance plans for safety monitoring. Due to decreased use and potential toxicity, strict prescribing and monitoring are enforced. For expert support in regulatory dossier preparation, compliance, and registration, visit PharmaTradz. We ensure seamless market access aligned with European and US standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing